Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Schwehm

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Deutsches Arzteblatt International|December 19, 2009
Influenza--insights from mathematical modellingRafael Mikolajczyk, Ralf Krumkamp, Reinhard Bornemann, et al.
Swiss Medical Weekly|August 14, 2009
Effects of interventions on the demand for hospital services in an influenza pandemic: a sensitivity analysisBeatriz Vidondo, Jürgen Oberreich, Stefan O Brockmann, et al.
The New Zealand Medical Journal|October 29, 2020
Detecting the re-emergent COVID-19 pandemic after elimination: modelling study of combined primary care and hospital surveillanceNick Wilson, Markus Schwehm, Ayesha J Verrall, et al.
Paediatric Drugs|June 9, 2016
Estimates of the Public Health Impact of a Pediatric Vaccination Program Using an Intranasal Tetravalent Live-Attenuated Influenza Vaccine in BelgiumLaetitia Gerlier, Mark Lamotte, Sofia Dos Santos Mendes, et al.
BMC Infectious Diseases|July 5, 2014
4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in GermanyMartin Eichner, Markus Schwehm, Johannes Hain, et al.
Journal of Medical Economics|March 25, 2021
Cost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in GermanyRui Cai, Laetitia Gerlier, Martin Eichner, et al.
Virology Journal|November 1, 2008
Modeling the effects of drug resistant influenza virus in a pandemicStefan O Brockmann, Markus Schwehm, Hans-Peter Duerr, et al.
BMC Infectious Diseases|January 22, 2009
Antiviral prophylaxis during pandemic influenza may increase drug resistanceMartin Eichner, Markus Schwehm, Hans-Peter Duerr, et al.
Journal of Health Economics and Outcomes Research|September 4, 2023
Direct and Indirect Protection with Pediatric Quadrivalent Live-Attenuated Influenza Vaccination in Europe Estimated by a Dynamic Transmission ModelLaetitia Gerlier, Judith Hackett, Richard Lawson, et al.
Human Vaccines & Immunotherapeutics|October 25, 2019
Assessing direct and indirect effects of pediatric influenza vaccination in Germany by individual-based simulationsRuprecht Schmidt-Ott, Daniel Molnar, Anastassia Anastassopoulou, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Deutsches Arzteblatt International|December 19, 2009
Influenza--insights from mathematical modellingRafael Mikolajczyk, Ralf Krumkamp, Reinhard Bornemann, et al.
Swiss Medical Weekly|August 14, 2009
Effects of interventions on the demand for hospital services in an influenza pandemic: a sensitivity analysisBeatriz Vidondo, Jürgen Oberreich, Stefan O Brockmann, et al.
The New Zealand Medical Journal|October 29, 2020
Detecting the re-emergent COVID-19 pandemic after elimination: modelling study of combined primary care and hospital surveillanceNick Wilson, Markus Schwehm, Ayesha J Verrall, et al.
Paediatric Drugs|June 9, 2016
Estimates of the Public Health Impact of a Pediatric Vaccination Program Using an Intranasal Tetravalent Live-Attenuated Influenza Vaccine in BelgiumLaetitia Gerlier, Mark Lamotte, Sofia Dos Santos Mendes, et al.
BMC Infectious Diseases|July 5, 2014
4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in GermanyMartin Eichner, Markus Schwehm, Johannes Hain, et al.
Journal of Medical Economics|March 25, 2021
Cost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in GermanyRui Cai, Laetitia Gerlier, Martin Eichner, et al.
Virology Journal|November 1, 2008
Modeling the effects of drug resistant influenza virus in a pandemicStefan O Brockmann, Markus Schwehm, Hans-Peter Duerr, et al.
BMC Infectious Diseases|January 22, 2009
Antiviral prophylaxis during pandemic influenza may increase drug resistanceMartin Eichner, Markus Schwehm, Hans-Peter Duerr, et al.
Journal of Health Economics and Outcomes Research|September 4, 2023
Direct and Indirect Protection with Pediatric Quadrivalent Live-Attenuated Influenza Vaccination in Europe Estimated by a Dynamic Transmission ModelLaetitia Gerlier, Judith Hackett, Richard Lawson, et al.
Human Vaccines & Immunotherapeutics|October 25, 2019
Assessing direct and indirect effects of pediatric influenza vaccination in Germany by individual-based simulationsRuprecht Schmidt-Ott, Daniel Molnar, Anastassia Anastassopoulou, et al.
Pageof 3